Skip to main navigation Skip to search Skip to main content

Pediatric mixed‐phenotype acute leukemia: What’s new?

Research output: Contribution to journalReview articlepeer-review

Abstract

Mixed‐phenotype acute leukemias (MPAL) are rare in children and often lack consensus on optimal management. This review examines the current controversies and emerging paradigms in the management of pediatric MPAL. We examine risk stratification, outcomes of recent retrospective and prospective collaborative trials, and the role of transplantation and precision genomics, and outline emerging targets and concepts in this rare entity.

Original languageEnglish (US)
Article number4658
JournalCancers
Volume13
Issue number18
DOIs
StatePublished - Sep 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Pediatric mixed‐phenotype acute leukemia: What’s new?'. Together they form a unique fingerprint.

Cite this